quinoxalines has been researched along with cefotaxime in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugaeva, OK; Makarovskaya, LN; Pavlovich, NV; Ryzhkova, VV; Zurabyan, VA | 1 |
| Belykh, SI; Klochikhin, AL; Larichev, AB; Markov, GI; Movergoz, SV | 1 |
| El-Hawash, SA; Habib, NS; Kassem, MA | 1 |
3 other study(ies) available for quinoxalines and cefotaxime
| Article | Year |
|---|---|
[In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Complement Activation; Doxycycline; Erythromycin; Furazolidone; Guinea Pigs; Humans; Microbial Sensitivity Tests; Penicillin G; Penicillins; Plague; Polymyxin B; Quinoxalines; Rifampin; Yersinia pestis | 1997 |
[Possibilities if intraoperative local administration of antibiotics and antiseptics in patients with ENT cancer].
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Cefotaxime; Drug Combinations; Female; Humans; Intraoperative Period; Male; Middle Aged; Otorhinolaryngologic Neoplasms; Polymethacrylic Acids; Povidone; Quinoxalines; Surgical Wound Infection; Treatment Outcome; Wound Healing | 2003 |
Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
Topics: Anti-Infective Agents; Antineoplastic Agents; Candida albicans; Cefotaxime; Cell Line, Tumor; Cell Survival; Dimethylformamide; Dose-Response Relationship, Drug; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Structure; Nystatin; Quinoxalines; Staphylococcus aureus; Structure-Activity Relationship; Triazoles | 2006 |